Applying Real-Time Data, Advanced Analytics & AI, & Demonstrating the ROI of Investment in Process Monitoring to Improve Quality, Yield, & Manufacturing Decision-Making
The process monitoring market is set to grow from $5.51 billion to $13.30 billion by 2032.
With regulators raising expectations around in-process controls, real-time monitoring, and lifecycle verification, and biopharma organizations increasing investment in PAT, manufacturing intelligence, and advanced analytics; process monitoring has become a critical strategic priority. At the same time, expanding biologics pipelines and advanced modalities are increasing complexity. Global manufacturing networks are placing additional pressure on teams to maximize yield, ensure consistency, and improve operational efficiency without increasing risk. In today’s environment, the challenge is no longer collecting data, but turning it into faster, more confident and impactful decisions across the product lifecycle.
The cancelled Process Monitoring in Pharma Manufacturing Summit (formerly the PAT & Real Time Quality Summit) was where industry leaders come to turn ambition into execution. Designed for pharma, biotech, and CDMO teams driving process performance, the meeting would have focused on shifting from fragmented tools to integrated, end-to-end monitoring strategies that deliver real business impact.
I’m looking forward to exchanging insights and best practices while learning from fellow industry leaders.
Ramila Peiris, Global Head of Data Management, Machine Learning, Artificial Intelligence Platform, Manufacturing Science & Technology Information Technology, Sanofi
The value of attending this meeting is the opportunity to learn how others across the industry are applying new process monitoring and analytical technologies to improve process understanding, control, and manufacturing readiness. These discussions are valuable for benchmarking approaches, identifying common challenges, and shaping future implementation strategies.
Hanzhou Feng, Associate Principal Scientist, Data Rich Measurements, Merck & Co.
I am excited to broaden my understanding of different PAT technologies and apply more robust control strategies to our gene therapy products.
Jan Panteli, Senior Director, Upstream Process Development, Gene Therapy Medical & Health, Ultragenyx
I look forward to connecting with the current state of the Pharma industry in transformative topics such as Real Time Decision Making, Continuous Manufacturing, AI Companion, and align on common pain points/concerns that need to be resolved with the Regulatory Environment.
Luc Nguyen, Global Head, Process Controls Strategies, Sanofi
Explore Related Events
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself as the partner of choice, being the frontrunners helping Process Performance, PAT, MSAT, Tech Transfer, Analytics, and Quality teams achieve their operational milestones.
Join Biopharma & Commercial Manufacturing Experts
Connect with professionals from pharma, biotech, CMOs and CDMOs who are working across distinctive modalities, and make critical connections during our dedicated networking sessions.